Amber D. Steele

Array ( [id] => 5480795 [patent_doc_number] => 20090203752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'COMPOUNDS FOR NONSENSE SUPPRESSION, AND METHODS FOR THEIR USE' [patent_app_type] => utility [patent_app_number] => 11/577192 [patent_app_country] => US [patent_app_date] => 2005-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 21885 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203752.pdf [firstpage_image] =>[orig_patent_app_number] => 11577192 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4860341 [patent_doc_number] => 20080269191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Compounds for Nonsense Suppression, Use of These Compounds for the Manufacture of a Medicament for Treating Somatic Mutation-Related Diseases' [patent_app_type] => utility [patent_app_number] => 11/577176 [patent_app_country] => US [patent_app_date] => 2005-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 39250 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269191.pdf [firstpage_image] =>[orig_patent_app_number] => 11577176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10594392 [patent_doc_number] => 09315467 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-19 [patent_title] => 'Compounds for nonsense suppression, and methods for their use' [patent_app_type] => utility [patent_app_number] => 11/577189 [patent_app_country] => US [patent_app_date] => 2005-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 36550 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11577189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5194773 [patent_doc_number] => 20070083258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-12 [patent_title] => 'Intraluminal device and therapeutic agent combination for treating aneurysmal disease' [patent_app_type] => utility [patent_app_number] => 11/244903 [patent_app_country] => US [patent_app_date] => 2005-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 62565 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20070083258.pdf [firstpage_image] =>[orig_patent_app_number] => 11244903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4887748 [patent_doc_number] => 20080262080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Allergy Suppressive Agent' [patent_app_type] => utility [patent_app_number] => 11/664622 [patent_app_country] => US [patent_app_date] => 2005-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10773 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20080262080.pdf [firstpage_image] =>[orig_patent_app_number] => 11664622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4887623 [patent_doc_number] => 20080261955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Use of Pharmaceutical Compositions of Lofepramine for the Treatment of Adhd, Cfs, Fm and Depression' [patent_app_type] => utility [patent_app_number] => 11/576325 [patent_app_country] => US [patent_app_date] => 2005-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7365 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20080261955.pdf [firstpage_image] =>[orig_patent_app_number] => 11576325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 44181 [patent_doc_number] => 07776886 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-17 [patent_title] => 'Cyclopropyl piperidine glycine transporter inhibitors' [patent_app_type] => utility [patent_app_number] => 11/664190 [patent_app_country] => US [patent_app_date] => 2005-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10275 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/776/07776886.pdf [firstpage_image] =>[orig_patent_app_number] => 11664190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5171277 [patent_doc_number] => 20070071708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Anhydrous hair compositions comprising a phosphate ester' [patent_app_type] => utility [patent_app_number] => 11/233836 [patent_app_country] => US [patent_app_date] => 2005-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2490 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20070071708.pdf [firstpage_image] =>[orig_patent_app_number] => 11233836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4840467 [patent_doc_number] => 20080280953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Agents Used for the Treatment of Seeds' [patent_app_type] => utility [patent_app_number] => 11/576355 [patent_app_country] => US [patent_app_date] => 2005-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13507 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20080280953.pdf [firstpage_image] =>[orig_patent_app_number] => 11576355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4976785 [patent_doc_number] => 20070218016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'Use of Aroma Substance Mixtures as Agents Against Bad Breath' [patent_app_type] => utility [patent_app_number] => 11/575610 [patent_app_country] => US [patent_app_date] => 2005-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9672 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20070218016.pdf [firstpage_image] =>[orig_patent_app_number] => 11575610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4926941 [patent_doc_number] => 20080166304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'Inactivation of Microorganisms With Multidrug Resistance Inhibitors and Phenothiaziniums' [patent_app_type] => utility [patent_app_number] => 11/662977 [patent_app_country] => US [patent_app_date] => 2005-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 11219 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20080166304.pdf [firstpage_image] =>[orig_patent_app_number] => 11662977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5247924 [patent_doc_number] => 20070244158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'Piperdine Compound and Process for Preparing the Same' [patent_app_type] => utility [patent_app_number] => 11/660046 [patent_app_country] => US [patent_app_date] => 2005-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22025 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20070244158.pdf [firstpage_image] =>[orig_patent_app_number] => 11660046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4965865 [patent_doc_number] => 20080108685 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'Novel Use for Alpha Sympathomimetics Having a 2-Imidazoline Structure' [patent_app_type] => utility [patent_app_number] => 11/664610 [patent_app_country] => US [patent_app_date] => 2005-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2697 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20080108685.pdf [firstpage_image] =>[orig_patent_app_number] => 11664610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5310830 [patent_doc_number] => 20090018111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'Novel Antimicrobial Medicament' [patent_app_type] => utility [patent_app_number] => 11/664810 [patent_app_country] => US [patent_app_date] => 2005-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10638 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20090018111.pdf [firstpage_image] =>[orig_patent_app_number] => 11664810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5739022 [patent_doc_number] => 20060009413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Methods and compositions for protecting or treating muscarinic receptors through administration of pyrophosphate analog in subjects exposed to toxic or carcinogenic metals or metal ions' [patent_app_type] => utility [patent_app_number] => 11/220115 [patent_app_country] => US [patent_app_date] => 2005-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 10602 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20060009413.pdf [firstpage_image] =>[orig_patent_app_number] => 11220115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9581679 [patent_doc_number] => 08771681 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-08 [patent_title] => 'Methods and compositions for protecting and treating muscarinic receptors by administering a pyrophosphate analog to a subject exposed to bacterial, fungal, viral, prion or algal infection' [patent_app_type] => utility [patent_app_number] => 11/220223 [patent_app_country] => US [patent_app_date] => 2005-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 10625 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11220223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10031456 [patent_doc_number] => 09072756 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-07 [patent_title] => 'Methods and compositions for increasing the efficacy of an agent that directly or indirectly affects a muscarinic receptor through administration of a pyrophosphate analog' [patent_app_type] => utility [patent_app_number] => 11/220222 [patent_app_country] => US [patent_app_date] => 2005-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 10623 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11220222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4813928 [patent_doc_number] => 20080194559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Remedy for Angiospasm Accompanying Subarachnoid Hemorrhage Containing Thrombin Receptor Antagonist as the Active Ingredient' [patent_app_type] => utility [patent_app_number] => 11/667420 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8042 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194559.pdf [firstpage_image] =>[orig_patent_app_number] => 11667420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4944487 [patent_doc_number] => 20080081814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-03 [patent_title] => 'Carbonyl Compounds Which Can be Used as Inhibitors of Coagulation Factor Xa' [patent_app_type] => utility [patent_app_number] => 11/576207 [patent_app_country] => US [patent_app_date] => 2005-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16107 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20080081814.pdf [firstpage_image] =>[orig_patent_app_number] => 11576207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4873699 [patent_doc_number] => 20080200433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'Molecular Chaperone Function Regulator' [patent_app_type] => utility [patent_app_number] => 11/661413 [patent_app_country] => US [patent_app_date] => 2005-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8349 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20080200433.pdf [firstpage_image] =>[orig_patent_app_number] => 11661413 [rel_patent_id] =>[rel_patent_doc_number] =>)